What is the recommended protocol for subcutaneous GHK-Cu (Glycyl-Histidyl-Lysine-Copper) administration in a 50-year-old male, 76kg, 1.73m, with significant weight loss, currently taking tirzepatide (Mounjaro), regarding dose, cycle, frequency, and duration?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board

Educational purpose only • Exercise caution as content is pending human review

Article Review Status

Submitted

Under Review

Approved

Last updated: January 8, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

What is the role of Tirzepatide (a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist) in weight loss for adults with obesity or overweight and at least one weight-related condition, including those with type 2 diabetes?

What is the typical dosing regimen for terzipatide (glucagon-like peptide-1 (GLP-1) and glucagon receptor agonist) for weight loss?

Can a patient who has plateaued in weight loss after losing 40 kg on 10 mg of tirzepatide (glucagon-like peptide-1 (GLP-1) receptor agonist) be escalated to 12.5 mg or 15 mg for further weight loss?

Can I continue tirzepatide (glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist) at a maintenance dose of 8mg weekly for weight loss maintenance?

How to manage hair loss in a patient on tirzepatide (glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist) who has experienced significant weight loss?

Can a patient with Alzheimer's disease undergoing Donanemab (aducanumab) therapy have surgery?

What are the management and treatment options for a patient who develops redness below the injection site after receiving a Diphtheria, Tetanus, and Pertussis (DTP) booster vaccination, suggesting a mild allergic reaction?

What additional treatments should be ordered for an ESRD (End-Stage Renal Disease) patient on hemodialysis (HD) 3 times a week with chest congestion, cardiomegaly, and bilateral lower lung zone opacities, already on Mucinex (Guaifenesin) and Duonebs (Albuterol and Ipratropium), with a complex medical history including hypertension, hyperlipidemia, hypocalcemia, anemia, and dementia?

What are the appropriate diagnostic and treatment steps for a patient experiencing bleeding during anal intercourse, potentially indicating a sexually transmitted infection (STI) or anal trauma?

What is the appropriate workup for a patient with external hemorrhoids, presenting with rectal bleeding, dark and bright red stools, fatigue, and weakness, who refuses hospitalization at a Skilled Nursing Facility (SNF)?

What is the maximum daily potassium replacement target for a patient with hypokalemia, considering factors such as severity of hypokalemia, renal function, and presence of other electrolyte imbalances?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.